Evidence and advocacy: Are all things considered?

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 13, 2006, Pages 1856-1857

  Johnson, Jeffrey A ^a,c   Edwards, Alun L ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE;

CANADA; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; MEDICAL SOCIETY; NOTE; PRACTICE GUIDELINE;

EID: 33745639677     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060231     Document Type: Note

References (10)

1. Clinical practice guidelines and conflict of interest [editorial; published erratum in CMAJ 2005;174(1):167]. CMAJ 2005;173(11):1297, 1299.
2. Howlett MC, Lillie D. The Canadian Diabetes Association guidelines: putting the evidence first. CMAJ 2006;174(3):333-4.
3. Laupacis A. On bias and transparency in the development of influential recommendations. CMAJ 2006;174(3):335-6.
4. Canadian Diabetes Association. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998;159(Suppl 8):S1-29.
5. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. 2003 clinical practice guidelines for the prevention and treatment of diabetes. Can J Diabetes 2003;27:Suppl 2.
6. Graham I, Beardall S, Carter AO, et al. What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ 2001;165(2):157-63.
7. Leape LL, Park RE, Kahan JP, et al. Group judgments of appropriateness: the effect of panel composition. Qual Assur Health Care 1992;4:151-9.
8. Harris SB, McFarlane P, Lank CN. Consensus, cost-effectiveness and clinical practice guidelines [letter response]. Can J Diabetes 2005;29:376-8.
9. Ramsey SD. Economic analyses and clinical practice guidelines: Why not a match made in heaven? J Gen Intern Med 2002;17:235-7.
10. Wallace JF, Weingarten SR, Chiun-Fang C, et al. The limited incorporation of economic analyses in clinical practice guidelines. J Gen intern Med 2002;17:210-20.